Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Iron Deficiency and Fibroblast Growth Factor 23 Regulation in Chronic Kidney Disease and Heart Failure

NCT03106298 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT03106298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03106298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Iron Deficiency and Fibroblast Growth Factor 23 Regulation in Chronic Kidney Disease and Heart Failure
Lead sponsor
Northwestern University
Phase
Observational
Overall status
Completed
Start date
December 18, 2015
Completion date
August 1, 2018
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure, chronic kidney diseases, iron deficiency anemia